What is the appropriate work‑up for evaluating hemolytic anemia?

Evaluation of Hemolytic Anemia

Begin with a complete blood count, reticulocyte count, peripheral blood smear, lactate dehydrogenase (LDH), haptoglobin, indirect bilirubin, and direct antiglobulin test (DAT/Coombs) to establish hemolysis and differentiate immune from non-immune causes 1, 2.

Initial Laboratory Workup

The diagnostic approach follows a systematic algorithm:

Step 1: Confirm Hemolysis

When you encounter anemia with thrombocytopenia, immediately order:

• Haptoglobin (decreased in hemolysis)
• LDH (elevated, marker of intravascular hemolysis)
• Indirect/unconjugated bilirubin (elevated)
• Reticulocyte count (typically elevated unless bone marrow suppression present) 3, 2, 4

Critical caveat: Reticulocytopenia occurs in 20-40% of autoimmune hemolytic anemia cases and indicates poor prognosis. This can result from marrow involvement, iron/vitamin deficiency, infections, or autoimmune reaction against bone marrow precursors 4.

Step 2: Peripheral Blood Smear Examination

This is mandatory and provides crucial morphological clues 2:

• Spherocytes: suggest hereditary spherocytosis or immune hemolysis
• Schistocytes >1%: indicates thrombotic microangiopathy (though absence doesn't exclude early TMA) 3
• Echinocytes: seen in pyruvate kinase deficiency, especially post-splenectomy (3-30%) 5
• Sickle cells: sickle cell disease
• Target cells: thalassemia or hemoglobinopathies

Important: In pyruvate kinase deficiency and other red cell enzyme defects, morphology is usually unremarkable with only anisocytosis and poikilocytosis 5.

Step 3: Direct Antiglobulin Test (DAT/Coombs)

This is the critical branching point that divides your differential 1, 2:

DAT-Positive (Immune Causes):

• Autoimmune hemolytic anemia
• Drug-induced hemolytic anemia
• Delayed hemolytic transfusion reactions

DAT-Negative (Non-Immune Causes):

• Hereditary membranopathies (spherocytosis, elliptocytosis)
• Red cell enzyme deficiencies (G6PD, pyruvate kinase)
• Hemoglobinopathies (sickle cell, thalassemia)
• Microangiopathic hemolytic anemias
• Paroxysmal nocturnal hemoglobinuria

Additional Testing Based on Clinical Context

For Suspected Thrombotic Microangiopathy

When the triad of non-immune hemolytic anemia, thrombocytopenia, and renal involvement (hematuria/proteinuria/elevated creatinine) is present 3:

• ADAMTS13 activity urgently (<10 IU/dL indicates TTP) 3
• Stool for verocytotoxin-producing E. coli (VTEC) to exclude STEC-HUS 3

For Intravascular Hemolysis

Marked LDH elevation suggests intravascular hemolysis. Add:

• Hemosiderinuria (typical of paroxysmal nocturnal hemoglobinuria, prosthetic valves) 4
• Hyperferritinemia (associated with chronic hemolysis) 4

For Microcytic Hemolytic Anemia

• Serum iron, total iron-binding capacity, ferritin (iron deficiency vs. thalassemia)
• Hemoglobin electrophoresis (hemoglobinopathies)
• Erythrocyte size-distribution width (helps distinguish iron deficiency from thalassemia minor) 6

For Hereditary Enzyme Deficiencies

When immune causes, membrane defects, unstable hemoglobin, and PNH are excluded 5:

• Spectrophotometric assay of red blood cell pyruvate kinase activity
• G6PD enzyme assay
• Genetic testing (PKLR gene sequencing for pyruvate kinase deficiency; next-generation sequencing panels for heterogeneous cases) 5, 7

Key point: Study parents and family members to confirm heterozygous enzyme deficiency states, particularly in transfusion-dependent cases 5.

Special Populations

Neonates

Consider hemolytic anemia when:

• Unexplained severe hyperbilirubinemia
• Rapid onset anemia in neonatal period 2
• Check maternal antibody titers and ADCC if non-ABO hemolytic disease suspected 8

Children <1 Year Old

When aHUS presents, consider:

• Complement-unrelated genes (DGKE, WT1) 3
• Inborn errors of cobalamin metabolism (MMACHC causing methylmalonic acidemia with homocystinuria) 3

Transfusion-Dependent Patients

Consider pyruvate kinase deficiency in transfusion-dependent patients without obvious etiology, or when reticulocytosis increases paradoxically after splenectomy 5.

Common Pitfalls to Avoid

1. Don't exclude TMA based on absent schistocytes alone - sensitivity is low, especially early in disease 3
2. Don't assume adequate reticulocyte response - 20-40% of AIHA cases have reticulocytopenia 4
3. Don't overlook iron status - ferritin and transferrin saturation may be disproportionately elevated in pyruvate kinase deficiency even without transfusions 5
4. Don't forget osmotic fragility is unreliable - can be normal or altered in enzyme deficiencies 5